MARKET

KLRA

KLRA

Kailera Therapeutics
NASDAQ
22.75
+0.45
+2.02%
Opening 10:05 05/13 EDT
OPEN
22.50
PREV CLOSE
22.30
HIGH
23.39
LOW
21.76
VOLUME
22.61K
TURNOVER
--
52 WEEK HIGH
28.23
52 WEEK LOW
20.87
MARKET CAP
2.95B
P/E (TTM)
-18.8891
1D
5D
1M
3M
1Y
5Y
1D
Hengrui Pharma, Kailera Therapeutics To Present Two Abstracts At 86th Scientific Sessions Of The American Diabetes Association
Benzinga · 2h ago
Kailera presents Phase 1 ribupatide injection data supporting global Phase 3 KaiNETIC program at ADA
PUBT · 2h ago
Kailera Therapeutics Price Target Announced at $36.00/Share by Leerink Partners
Dow Jones · 16h ago
Kailera Therapeutics Price Target Announced at $48.00/Share by Jefferies
Dow Jones · 16h ago
Jefferies Initiates Coverage On Kailera Therapeutics with Buy Rating, Announces Price Target of $48
Benzinga · 16h ago
Kailera Therapeutics Initiated at Outperform by Evercore ISI Group
Dow Jones · 22h ago
Evercore ISI Group Initiates Coverage On Kailera Therapeutics with Outperform Rating
Benzinga · 22h ago
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 22h ago
More
About KLRA
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.

Webull offers Kailera Therapeutics Inc stock information, including NASDAQ: KLRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KLRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KLRA stock methods without spending real money on the virtual paper trading platform.